Stock Market Today (18 September 2026): Adani Green, Vedanta, Hero MotoCorp, Medanta and Tata Chemicals in Focus

Key Market Highlights

Adani Green Energy: Jefferies Highlights Expansion Potential

Adani Green Energy remained in focus after Jefferies initiated a positive view with a target price of ₹1,695. The brokerage highlighted the company's expansion plans, including a proposed 10 GWh battery energy storage system capacity by FY27.

The development comes as investors continue to track Adani Green's renewable-energy capacity additions, project execution and capital requirements. The brokerage's stated target implies significant upside from the reference level reported in the market update, although target prices represent analyst estimates rather than guaranteed returns.

Vedanta: ₹3,500 Crore NCD Issue in Focus

Vedanta announced plans to issue ₹3,500 crore of non-convertible debentures listed on the BSE. Separately, the company cleared share pledges following repayment of bonds, an update that investors may track from a capital-structure perspective.

ICRA also reaffirmed Vedanta's AA+ rating with a stable outlook, with no changes reported to the company's NCD ratings. The combination of fundraising activity, debt repayment and rating commentary keeps Vedanta's balance sheet and financing strategy in focus.

Hero MotoCorp: JPMorgan Sets ₹6,845 Target

Hero MotoCorp attracted attention after JPMorgan set a ₹6,845 target price, citing growth opportunities linked to electric vehicles and scooters. The brokerage's report pointed to the company's evolving product mix and potential growth in the two-wheeler market.

Hero MotoCorp also received an ESG score of 74 from Niche Ninety Nine. Investors are likely to monitor scooter launches, EV adoption, margins and overall volume growth as key operating indicators.

Medanta: Q2 Profit Reaches ₹197.2 Crore

Global Health, which operates the Medanta hospital network, reported Q2 profit of ₹197.2 crore. The stock was trading around ₹1,437, while Investec maintained a ₹1,730 target and highlighted the company's growth potential.

Bed capacity has increased by 47%, strengthening the company's expansion profile. Capacity additions, occupancy levels, case mix and operating margins remain important metrics for tracking the healthcare company's earnings trajectory.

Engineers India: 37% PAT Growth and Strong Order Book

Engineers India reported 37% growth in profit after tax and highlighted an order book of ₹15,109 crore. Separate company updates put the order book at around ₹170 billion, underscoring the scale of its ongoing project pipeline.

The company is also targeting FY26 turnover of ₹3,849 crore. Execution of the existing order book, new project wins and conversion of the pipeline into revenue will remain key factors for investors.

GPT Infra: Shares Jump on ₹484 Crore RVNL Deal

GPT Infraprojects gained attention after securing a ₹484 crore order from Rail Vikas Nigam Limited. The company has also reported an order book of around ₹5,000 crore and is targeting additional orders worth ₹3,000 crore by FY27.

The fresh RVNL contract strengthens visibility for the infrastructure company, with execution speed, margins and future order inflows likely to remain key variables.

Tata Chemicals: Shares Slide; ₹11 Final Dividend Declared

Tata Chemicals came under pressure during the session, with the stock reported down around 7.5%. The move occurred alongside weakness across several Tata Group stocks amid reports concerning differences related to Tata Sons' listing plans.

Separately, Tata Chemicals declared a final dividend of ₹11 per share for FY25. The corporate action provides a separate focus for shareholders even as the stock faces near-term market volatility.

Nestle India: FSSAI Developments Keep Stock in Focus

Nestle India faced selling pressure after FSSAI-related developments concerning three products. Reports indicated legal action and regulatory scrutiny related to compliance issues, while a later company update stated that there was no impact from the FSSAI development and that its products remained compliant.

With regulatory developments evolving, investors should distinguish between reported allegations or proceedings and the company's subsequent clarification. Further regulatory updates may remain important for the stock.

Pine Labs: Vanguard Buys Shares as Stock Recovers

Pine Labs rebounded around 3% after an earlier decline linked to UPI MDR developments. Vanguard reportedly purchased around 8.5 million shares for approximately ₹164 crore, adding institutional activity to the stock's near-term narrative.

JPMorgan also raised its Pine Labs target to ₹190 while retaining a Neutral rating. Investors are likely to track the company's earnings outlook, payment economics and the impact of changes in UPI merchant discount rates.

Other Stocks in Focus

Market Outlook

The session's key themes were renewable-energy expansion, infrastructure orders, capital raising, healthcare capacity growth and brokerage-driven stock moves. Adani Green's planned battery-storage expansion, Engineers India's sizeable order book and GPT Infra's RVNL contract provide company-specific catalysts, while Vedanta's fundraising and Tata Chemicals' dividend remain important corporate developments.

At the same time, regulatory developments around Nestle India and the continued focus on UPI payment economics for Pine Labs highlight the importance of monitoring policy and regulatory changes. Going forward, investors may focus on order execution, earnings growth, capacity additions, leverage, margins and cash-flow generation rather than relying solely on brokerage targets or short-term price movements.

Stocks to Watch

Adani Green Energy, Vedanta, Hero MotoCorp, Medanta (Global Health), Engineers India, GPT Infra, Tata Chemicals, Pine Labs, Gujarat Themis Biosyn, Bombay Burmah and Timex India are among the stocks to watch following today's major developments.